Trials / Completed
CompletedNCT04289649
K-924 Phase III Confirmatory Study
A Phase III, Multicenter, Randomized, Clinial Trial to Evaluate the Efficacy and Safety of K-924 in Patienta With Hypercholesterolemia.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 293 (actual)
- Sponsor
- Kowa Company, Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
A multicenter, active-controlled, randomized, double-blind comparative study to compare the efficacy and safety of K-924 LD tablet or K-924 HD tablet to pitavastatin 2 mg or 4 mg in patienta with hypercholesterolemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | K-924 LD | Pitavastatin 2 mg / Ezetimibe 10 mg tables |
| DRUG | K-924 HD | Pitavastatin 4 mg / Ezetimibe 10 mg tables |
| DRUG | K-924 LD Placebo | Pitavastain 2 mg |
| DRUG | K-924 HD Placebo | Pitavastain 4 mg |
Timeline
- Start date
- 2020-04-02
- Primary completion
- 2020-11-21
- Completion
- 2020-11-21
- First posted
- 2020-02-28
- Last updated
- 2023-11-29
Locations
3 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT04289649. Inclusion in this directory is not an endorsement.